Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains

I Stock1

  • 1Rheinische Friedrich-Wilhelm-Universität Bonn, Institut für Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany. Ingo_Stock@web.de

Insights

This study details the natural antibiotic resistance and susceptibility of Proteus mirabilis and Proteus penneri. Key differences were found in tetracyclines, beta-lactams, and other agents, impacting clinical assessments.

Area of Science:

  • Clinical Microbiology
  • Antimicrobial Resistance
  • Bacterial Pathogenesis

Background:

  • Proteus species are significant opportunistic pathogens.
  • Understanding natural antibiotic susceptibility is crucial for effective treatment and diagnostic test validation.
  • Limited data exists on the comparative natural antibiotic profiles of Proteus mirabilis and Proteus penneri.

Purpose of the Study:

  • To comprehensively assess the natural antibiotic susceptibility of Proteus mirabilis and Proteus penneri strains.
  • To establish a database for validating future antibiotic susceptibility testing methods.
  • To identify species-specific differences in antimicrobial profiles.

Main Methods:

  • Tested 102 Proteus mirabilis and 35 Proteus penneri strains against 71 antibiotics.
  • Determined Minimum Inhibitory Concentrations (MICs) using microdilution in IsoSensitest and cation-adjusted Mueller Hinton broths.
  • Compared natural susceptibility patterns with existing literature.

Main Results:

  • Both species showed natural resistance to penicillin G, oxacillin, macrolides, lincosamides, streptogramins, glycopeptides, rifampicin, and fusidic acid.
  • Uniform natural sensitivity observed for aminoglycosides, acylureidopenicillins, carbapenems, aztreonam, quinolones, sulfamethoxazole, and co-trimoxazole.
  • Species-specific differences noted for tetracyclines, beta-lactams, chloramphenicol, and nitrofurantoin; P. mirabilis resistant to tetracyclines, P. penneri showed variable tetracycline and amoxicillin susceptibility.

Conclusions:

  • Established a valuable database on the natural antibiotic susceptibility of P. mirabilis and P. penneri.
  • Highlighted significant species-specific variations in susceptibility that influence clinical interpretation.
  • Confirmed the presence of naturally occurring beta-lactamase in P. mirabilis.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...